Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-guided Brachytherapy + Chemotherapy for Recurrent Rectal Cancer
NCT02423226Phase 2Completed
- Sponsor
- Changzhou First People's Hospital
- Start
- Oct 2008
- Primary completion
- Dec 2014
01
Overview
Phase 2, randomised, open-label trial in rectal cancer (2 arms), sponsored by Changzhou First People's Hospital. Primary endpoint: Progression Free Survival at 1 year. Started Oct 2008; status: completed.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02423226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423226.